Newsroom
AACR's Policy Statement Urges FDA-Regulation of Laboratory-Developed Tests
The statement points to the increased complexity of some of the LDTs and highlights patient safety issues that are at stake.
Premiums for ACA Insurance Plans Will Decline Slightly in 2015
In the largest cities in 15 states plus the District of Columbia the average insurance premiums for the second-lowest-cost silver plan will decline by 0.8% in 2015, according to an analysis from the Kaiser Family Foundation.
HHS Will Award $60 Million in Grants to Marketplace Navigators
The Department of Health and Human Services (HHS) announced it will award $60 million in Navigator grants to 90 organizations in states with federally facilitated and state partnership marketplaces.
DEA Moves to Curtail Drug Abuse
With the objective of reducing drug abuse, especially by teenagers, the D.E.A. will now allow patients and their relatives to mail-in their unneeded stockpiles of prescription drugs back to the pharmacies.
Global Study Identifies Prediabetes as a Risk Factor for Cancer
A meta-analysis comprising 16 studies and 891,426 participants from various regions of the world shows that prediabetes increases the risk of cancer by 15%, with differing risks depending on the type of cancer.
Androgen-Deprivation is Essential in Prostate Cancer Regimen
A joint statement by ASCO and CCO published new guidelines in the treatment of metastatic CRPC.
NICE Rejects Abraxane for Pancreatic Cancer
NICE does not deem Abraxane more effective than FOLFIRINOX, in addition to the fact that it causes severe side effects.
Superbugs an Increasing Problem in Hospitals
For patients who develop infections while staying in a hospital, the chances of it becoming drug resistant increases 1% for each day of hospitalization, according to researchers from the Medical University of South Carolina (MUSC).
Genomic Analysis Determines Post-Surgery Treatment in Prostate Cancer
The results of the genomic data can guide treatment decisions post-surgery in prostate cancer.
Hospitals, Providers Continue to Struggle with Stage 2 Meaningful Use
Numbers for Stage 2 meaningful use attestation remain very low, according to the latest numbers from the Centers for Medicare and Medicaid Services.
Massachusetts’ Foray Into Narrow Networks Shows Potential
The narrow health insurance networks that have become more common under the Affordable Care Act can reduce patient spending by as much as a third, according to research from MIT.
Bristol-Myers Sues Merck Over US Immunotherapy Patent
“Merck is threatening to exploit that invention,” known as immunotherapy, with a later-developed method of treatment, in violation of a May 20 patent, Bristol-Myers said in a lawsuit filed yesterday in federal court in Wilmington, Delaware. The New York-based company is seeking unspecified damages.
Companies Race To Adjust Health-Care Benefits As Affordable Care Act Takes Hold
Large businesses expect to pay between 4 and 5 percent more for health-care benefits for their employees in 2015 after making adjustments to their plans, according to employer surveys conducted this summer.
Highmark Takes on Outpatient Markups
Highmark, an insurer with its own health system, is challenging a growing and controversial billing practice that also happens to be a central part of some health system integration strategies.
New State Law on Generic Pricing Upsets PBMs
The law could restrict the use of less-expensive generics with the availability of newer, more-expensive drugs.
Telehealth and Health IT Policy: Considerations for Stakeholders
In recent months, as the conversation about reforming the health care system has shifted to achieving greater delivery system efficiencies, cost containment, and patient satisfaction, the role of health care technology—specifically, telehealth and health information technology (health IT or HIT), is becoming an ever more prevalent discussion topic among health policy stakeholders.
Many immigrants May Lose Health Insurance Under the ACA
Nearly a quarter of a million newly naturalized citizens or immigrants may lose their health insurance coverage under the Affordable Care Act at the end of the month.
Researchers Receive $23.8 Million Grant to Test an Innovative Model to Improve HIV Prevention and Care
Researchers at the George Washington University (GW) were awarded a grant estimated to be funded at $23.8 million from the Centers for Medicare & Medicaid Services (CMS) to study a new model that aims to improve HIV prevention and care while lowering healthcare costs.
Fee-For-Service May Introduce Treatment Bias in Radiation Oncology
The write believes that the episodic reimbursement model might introduce bias among radiation oncologists who own their own treatment equipment.
Hackers Gain Access to HealthCare.gov's Test Server
The Government says the site did not carry any personal information on consumers.
Will My Health Plan Be Cancelled?
Transitional plans that are non-compliant may be cancelled by the insurer or barred by some states.
Family History Alone May Not Tell the Tale in Jewish Women
Although family history is a risk factor, a new study has shown that it should not be the primary determinant of mutation screening for breast and ovarian cancer.
White House Appoints New Chief Technology Officer, Deputy
The White House named former Google executive Megan Smith as its new chief technology officer to succeed Athenahealth co-founder and HHS veteran Todd Park, who is credited with helping rescue HealthCare.gov.
Pembrolizumab Approved For Advanced Melanoma
Following a breakthrough therapy designation, pembrolizumab was included in FDA's accelerated approval program to allow early patient access.
Opdivo Reignites the Drug Pricing Discussion
While Sovaldi is still fresh on the mind, Ono Pharmaceutical's Opdivo (nivolumab), marketed jointly with BMS in Japan, has analysts projecting what the treatment might cost in the US.